.jpg "Tal Burt, MD photo")
President
Phase-0/Microdosing Network
Dr. Burt is a board-certified psychiatrist with 25-year experience in all phases of clinical development and particularly in the early-phase, proof-of-concept (POC), and microdosing stages of clinical development. He has authored 49 peer-reviewed publications in clinical research and drug development including original drug development methodologies such as Intra-Target Microdosing (ITM), randomized-withdrawal designs, assessment of the impact of false-negatives on the productivity of treatment development, the first publications of Vagus Nerve Stimulation (VNS) in major depression, the first comprehensive review of Transcranial Magnetic Stimulation (TMS), and a textbook on Outcomes Measurement in Clinical Psychiatry. He led early- and late-phase developmental programs of neuroscience compounds and is the founder of the Phase-0/Microdosing Network, an international organization of multidisciplinary stakeholders with interests in accelerating translational drug development. He is currently a Clinical Research and Clinical Development Consultant.
Disclosure information not submitted.